Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Gene therapy developer Freeline Therapeutics priced an upsized offering at the top of its range following $275m in funding from investors including Novo.

UCL's Freeline Therapeutics has priced its shares at $18 to raise nearly $159m through an IPO on the Nasdaq Global Select Market.

The GM-backed transport data provider has added $13.1m in a round led by existing investor DIP Capital and backed by the UK’s Future Fund.

Erstwhile Cambridge Innovation Capital chief executive Victor Christou has resurfaced to join YFM Equity Partners’ London offices.

NetScientific is poised to acquire EMV Capital in an all-share deal after appointing the latter's managing director as its chief executive in May.

The accelerator will award grant and equity funding to derisk quantum technologies over the next four years.

Cash realisations at IP Group rose massively as the firm swung into profit.

The UK regional tech transfer alliance's Seed Investment Fund expects to close its first investments in coming months, targeting sectors including healthcare and data.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.